SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Could Prompt Security be SentinelOne’s lifeline as shares slide 35% this year?

“Combined with AI and classical computing, quantum computing is the most dangerous tool we’ve ever had”

Women, work, and menopause: Navigating income, expenses, and career transitions

Harvard professor files $2M claim against insolvent tech founder Moshe Yanai amid $120M debt crisis

Buzz

Most popular

Daily

Weekly

1

“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals

2

Nice puts Actimize up for sale at a $1.5-2 billion price tag

3

Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program

4

Zafran raises $60 million and doubles valuation as it chooses independence over takeover offers

5

Israeli drone startup Heven hits $1 billion valuation in $100 million round led by IonQ

Wolves

2 stories about Wolves

Sam Lamm holding Romulus, one of the cubs

"We took a 73,000-year-old fossil and created puppies from it. It's just magic"

02.06.25|Roni Dori

Biotech venture Colossal Biosciences stunned the world in April with the announcement that it had genetically engineered the dire wolf, a species that went extinct 12,500 years ago. But the excitement over the birth of three white puppies was quickly tempered by criticism: skeptics argued this was not a true species revival and warned that such investments could divert attention and resources from the urgent effort to protect existing wildlife. In an exclusive interview, founder Ben Lamm explains how the complex process was achieved, and why he believes it could ultimately benefit the planet.

זאב בלהות ה זאבים של חברת הביוטכנולוגיה קולוסל ביוסיינסס

How the dire wolf became a $10 billion biotech fantasy

17.04.25|Shani Ashkenazi

Scientists fear de-extinction buzz could erode real-world conservation efforts and public trust in science.